Researchindicates that it possesses the ability to stimulate CD4+ and CD8+T-cells, interface with specialized antigen-presenting cells, thendestroy cancer cells or tissue.95 A personalizedpeptide vaccination was developed recently to enhance immune responseby using unique peptides for every patient, serving as a revolutionaryapproach to cancer treatment. The gene discussed is CD8A; the disease is cancer.